NZ603672A - Process for preparing pyrimidinone compounds - Google Patents

Process for preparing pyrimidinone compounds

Info

Publication number
NZ603672A
NZ603672A NZ60367211A NZ60367211A NZ603672A NZ 603672 A NZ603672 A NZ 603672A NZ 60367211 A NZ60367211 A NZ 60367211A NZ 60367211 A NZ60367211 A NZ 60367211A NZ 603672 A NZ603672 A NZ 603672A
Authority
NZ
New Zealand
Prior art keywords
formula
compound
treating
thio
heating
Prior art date
Application number
NZ60367211A
Other languages
English (en)
Inventor
Suzanne Helen Davies
Claire Frances Crawford
Kevin Stuart Cardwell
Charles Edward Wade
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44992024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ603672(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NZ603672A publication Critical patent/NZ603672A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NZ60367211A 2010-05-17 2011-05-17 Process for preparing pyrimidinone compounds NZ603672A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34522410P 2010-05-17 2010-05-17
PCT/US2011/036821 WO2011146494A1 (en) 2010-05-17 2011-05-17 Novel processes

Publications (1)

Publication Number Publication Date
NZ603672A true NZ603672A (en) 2015-01-30

Family

ID=44992024

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ60367211A NZ603672A (en) 2010-05-17 2011-05-17 Process for preparing pyrimidinone compounds

Country Status (25)

Country Link
US (2) US9447052B2 (enExample)
EP (1) EP2571857B1 (enExample)
JP (1) JP6027529B2 (enExample)
KR (1) KR20130089157A (enExample)
CN (2) CN103003249B (enExample)
AR (1) AR081399A1 (enExample)
AU (1) AU2011256270B2 (enExample)
BR (1) BR112012030532A2 (enExample)
CA (1) CA2799520C (enExample)
CL (1) CL2012003206A1 (enExample)
CO (1) CO6630197A2 (enExample)
CR (1) CR20120630A (enExample)
DO (1) DOP2012000289A (enExample)
EA (1) EA026569B1 (enExample)
IL (1) IL223068A0 (enExample)
MA (1) MA34301B1 (enExample)
MX (1) MX2012013387A (enExample)
NZ (1) NZ603672A (enExample)
PE (1) PE20130318A1 (enExample)
PH (1) PH12012502247A1 (enExample)
SG (1) SG185559A1 (enExample)
TW (1) TW201209043A (enExample)
UY (1) UY33388A (enExample)
WO (1) WO2011146494A1 (enExample)
ZA (1) ZA201208631B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY33388A (es) * 2010-05-17 2011-12-01 Glaxo Group Ltd Nuevos procesos para la preparacion de compuestos de pirimidinona
WO2015087239A1 (en) 2013-12-11 2015-06-18 Ranbaxy Laboratories Limited Processes for the preparation of darapladib and its intermediates
WO2015092687A2 (en) 2013-12-17 2015-06-25 Ranbaxy Laboratories Limited Process for the purification of darapladib
US11583596B2 (en) 2017-09-26 2023-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Radiolabeled Darapladib and analogs thereof and their use as imaging compounds
US10866963B2 (en) * 2017-12-28 2020-12-15 Dropbox, Inc. File system authentication

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1143516B (de) 1961-04-27 1963-02-14 Bayer Ag Verfahren zur Herstellung von Peptiden
US4277465A (en) 1978-08-26 1981-07-07 Kyoto Yakuhin Kogyo Kabushiki Kaisha Adjuvant for promoting absorption of therapeutically active substances through the digestive tract
US4235776A (en) * 1979-03-15 1980-11-25 Eli Lilly And Company Tetrahydro-2H-benzo[c]pyrroles
DE2941597A1 (de) * 1979-10-13 1981-04-23 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
US4619941A (en) * 1984-11-19 1986-10-28 American Cyanamid Company N-[(1H-imidazol-1-yl)alkyl]-1H-indolecarboxamides useful as thromboxane synthetase inhibitors and antihypertensive agents
JP2001522844A (ja) * 1997-11-06 2001-11-20 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ピリミジノン化合物およびそれを含有する医薬組成物
US6750228B1 (en) 1997-11-14 2004-06-15 Pharmacia Corporation Aromatic sulfone hydroxamic acid metalloprotease inhibitor
US6503745B1 (en) 1998-11-05 2003-01-07 Biocryst Pharmaceuticals, Inc. Cyclopentane and cyclopentene compounds and use for detecting influenza virus
PT1175408E (pt) 1999-05-01 2005-04-29 Smithkline Beecham Plc Derivados sulfonamida
BRPI0108396B1 (pt) * 2000-02-16 2015-05-19 Smithkline Beecham Plc Derivados de pirimidina-4-ona como inibidores de ldl-pla2
GB0119795D0 (en) * 2001-08-14 2001-10-03 Smithkline Beecham Plc Novel process
UY33388A (es) * 2010-05-17 2011-12-01 Glaxo Group Ltd Nuevos procesos para la preparacion de compuestos de pirimidinona

Also Published As

Publication number Publication date
KR20130089157A (ko) 2013-08-09
SG185559A1 (en) 2012-12-28
EP2571857B1 (en) 2017-08-23
EP2571857A4 (en) 2013-11-20
UY33388A (es) 2011-12-01
AU2011256270B2 (en) 2015-11-26
CO6630197A2 (es) 2013-03-01
MX2012013387A (es) 2012-12-10
JP6027529B2 (ja) 2016-11-16
IL223068A0 (en) 2013-02-03
AU2011256270A1 (en) 2012-12-20
CL2012003206A1 (es) 2013-01-25
TW201209043A (en) 2012-03-01
US9725420B2 (en) 2017-08-08
EA026569B1 (ru) 2017-04-28
WO2011146494A1 (en) 2011-11-24
CR20120630A (es) 2013-02-15
CA2799520C (en) 2016-09-13
US20130060028A1 (en) 2013-03-07
CN105837520A (zh) 2016-08-10
CN103003249A (zh) 2013-03-27
MA34301B1 (fr) 2013-06-01
EP2571857A1 (en) 2013-03-27
CA2799520A1 (en) 2011-11-24
BR112012030532A2 (pt) 2015-09-29
US20160347720A1 (en) 2016-12-01
EA201291235A1 (ru) 2013-04-30
JP2013530948A (ja) 2013-08-01
US9447052B2 (en) 2016-09-20
CN103003249B (zh) 2016-04-27
DOP2012000289A (es) 2013-04-15
PE20130318A1 (es) 2013-04-11
PH12012502247A1 (en) 2013-02-04
AR081399A1 (es) 2012-08-29
ZA201208631B (en) 2013-09-25

Similar Documents

Publication Publication Date Title
NZ603672A (en) Process for preparing pyrimidinone compounds
MY147440A (en) Process for making 3-substituted 2-amino-5-halobenzamides
TW200643014A (en) Chemical process
UA93424C2 (en) Preparation of azoxystrobin
CL2016000346A1 (es) Proceso para preparar compuestos intermediarios en la preparación de pirazolil pirrol pirimidinas.
EA033468B1 (ru) Способы получения конъюгата "антитело-майтансиноид"
MX2014006992A (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
AR073073A1 (es) Compuestos de pirrolo [ 2,3-d] pirimidina.
DK2057126T3 (da) Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater
WO2010125216A3 (es) Preparación de compuestos 5,6-dihidropirido[2,3-d]pirimidin-7(8h)-ona sustituidos
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
UA107344C2 (uk) Спосіб одержання 5-(2-{[6-(2,2-дифтор-2-фенілетокси)гексил]аміно}-1-гідроксіетил)-8-гідроксихінолін-2(1h)-ону
WO2012111027A3 (en) Process for pemetrexed disodium
GEP20105099B (en) Method for preparation of optionally 2-substituted 1,6- dihydrocarboxil acids
JP2013530948A5 (enExample)
WO2012087888A3 (en) Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt
MX2014003638A (es) Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida.
WO2013096819A3 (en) Macromolecule positioning by electrical potential
MY160308A (en) Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid
ATE553098T1 (de) Verfahren zur herstellung von rosuvastatin- calcium
NZ598278A (en) Process for preparing biphenyl imidazole compounds
WO2011109675A3 (en) Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide
NZ599218A (en) Process for the manufacture of organic compounds
UA93860C2 (ru) Способ получения пиразолов, способ региоселективного алкилирования и применение фосфата или фосфоната b способе
EA201300100A3 (ru) Способ ферментативного синтеза(7s)-3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбоновой кислоты или ее сложных эфиров, и применение для синтеза ивабрадина и его соли

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 MAY 2016 BY AJ PARK

Effective date: 20150826

LAPS Patent lapsed